Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations and Comprehensive Loss

v3.21.2
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Total revenue $ 181 $ 3,000 $ 568 $ 3,000
Operating expenses:        
Cost of goods sold 199   620  
Selling, general and administrative 10,438 4,089 28,351 11,021
Research and development 3,404 4,301 9,489 9,450
Total operating expenses 14,041 8,390 38,460 20,471
Loss from operations (13,860) (5,390) (37,892) (17,471)
Other income (expense):        
Change in fair value of warrant liability 1 (14) 6 (17)
Other income, net 51 75 127 170
Interest income 39 78 130 146
Interest expense       (29)
(Loss) gain on foreign currency exchange (2)   (6) 3
Total other income 89 139 257 273
Loss before income tax expense (13,771) (5,251) (37,635) (17,198)
Foreign income tax expense   (300)   (300)
Net loss and comprehensive loss $ (13,771) $ (5,551) $ (37,635) $ (17,498)
Per share information:        
Net loss per share of common stock, basic (in dollars per share) $ (0.08) $ (0.04) $ (0.23) $ (0.15)
Net loss per share of common stock, diluted (in dollars per share) $ (0.08) $ (0.04) $ (0.23) $ (0.15)
Weighted average common shares outstanding, basic (in shares) 164,510,570 144,335,143 162,811,136 117,420,221
Weighted average common shares outstanding, diluted (in shares) 164,510,570 144,335,143 162,811,136 117,420,221
Product revenue        
Revenue:        
Total revenue $ 112   $ 499  
License revenue        
Revenue:        
Total revenue $ 69 $ 3,000 $ 69 $ 3,000